Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co-use: research and measurement implications to move the field forward

Published by Michael on

Related Posts

Medical

Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action

Front Pharmacol. 2022 May 9;13:908198. doi: 10.3389/fphar.2022.908198. eCollection 2022. ABSTRACT Inflammation often develops from acute, chronic, or auto-inflammatory disorders that can lead to compromised organ function. Cannabis (Cannabis sativa) has been used to treat inflammation Read more…

Medical

Gambling in Ireland: profile of treatment episodes from a national treatment reporting system

Ir J Psychol Med. 2022 May 26:1-8. doi: 10.1017/ipm.2022.20. Online ahead of print. ABSTRACT OBJECTIVES: Globally, problem gambling prevalence is estimated at between 0.1% and 5.8%. Problem gambling can have many negative consequences; including on Read more…

Medical

Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative

Clin Exp Rheumatol. 2022 May 23. doi: 10.55563/clinexprheumatol/b85xu5. Online ahead of print. ABSTRACT OBJECTIVES: Medical cannabis is often used to alleviate common symptoms in patients with chronic conditions. With cannabis legalisation in Canada and easier Read more…

error: Content is protected !!